Formulary Decision-Making for Evolving Therapies -- A Case Example: Fluticasone and Asthma

A. Kathryn Power; Donald P. Galamaga

Robin L. Smith, MD

Stephen M. Davidson, PhD

Mary Lee Gora-Harper, PharmD

Antonio P. Legorreta, MD; Carolyn Kashian, MPH; Carolyn Franklin

J. Sandford Schwartz, MD; Allan Hillman, MD, MBA

James V. Fiorica, MD

Edward P. Havranek, MD; Gerard W. Graham; Zhaoxing Pana, MB, MS; Brian Lowes, MD

A. Mark Fendrick, MD; Michael Chernew, PhD; Richard Hirth, PhD; Devidas Menon, PhD, MHSA

Michael O. Gardner, MD, MPH; Dwight J. Rouse, MD; Robert L. Goldenberg, MD; Joyce Lanning, PhD; Elizabeth Thom, PhD; Julia Zachary; and the NICHD Maternal Fetal Unit Network

Joel W. Hay, PhD; Richard L. Ernst, PhD; H. Cody Meissner, MD

David R. Smith, MD; Herbert Y. Wong, PhD; John Eichert

Ron Lyon, MS, RPh

William N. Marshall, Jr., MD

Jean M. Mitchell, PhD; Reply by Carrie D. Cooper, MHA and Roy M. Arnold, MD, MHA

Donald Calcagno, Jr., MT; Mary Pubentz, PharmD; Raymond Carey, PhD

Ronald H. Joe, PharmD; Catherine B. Carter, DPh

Craig S. Stern, RPh, PharmD, MBA; Patrick D. Pothier, MBA

Cary Sennett, MD, PhD